188 jili org
188 jili org
OCALA, Fla.--(BUSINESS WIRE)--Nov 27, 2024-- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today issued the following statement refuting the false and misleading claims recently made by a group of activist investors (collectively, the “Activist Group”) relating to their multi-year attempt to take over AIM’s Board of Directors (the “Board”) at the upcoming 2024 Annual Meeting of Stockholders (the “Annual Meeting”), presently scheduled for December 17, 2024. Since 2016, the Board and management team have worked to overcome multiple obstacles, refocus the Company’s clinical development programs to high-value indications, improve its financial condition and lay the foundation for long-term shareholder value creation. To be clear, the Board and management are unhappy with the Company’s stock price performance – but they are doing everything possible to continue the significant momentum with Ampligen – which is ultimately what will create long-term value for all shareholders. Unfortunately, the Activist Group has accused AIM of lying about its historical share price. by claiming in its proxy statement: The truth is that AIM’s stock has never traded anywhere near such a price: Consider the following instances where its members have been found by the Delaware Court of Chancery (the “Court”) to have lied to or misled shareholders: Furthermore, the Court confirmed “ ” 10 by pursuing litigation against AIM. The Delaware Court of Chancery agreed with the Board in both 2022 and 2023. Following the Activist Group’s appeal, the Supreme Court of Delaware upheld the Court’s decision in favor of AIM earlier this year – . : AIM encourages shareholders to vote “ ” ALL four of the Board’s incumbent candidates – , , and – in connection with the Annual Meeting, on the universal proxy card. For more information on how to vote, visit: . *** AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s lead product is a first-in-class investigational drug called Ampligen ® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system. For more information, please visit and connect with the Company on , , and . This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “continue,” “believe,” “potential,” “upcoming” and other variations thereon and similar expressions (as well as other words or expressions referencing future events or circumstances) are intended to identify forward-looking statements. Many of these forward-looking statements involve a number of risks and uncertainties. Data, pre-clinical success and clinical success seen to date does not guarantee that Ampligen will be approved as a treatment or therapy for any diseases or conditions. The Company urges investors to consider specifically the various risk factors identified in its most recent Annual Report on Form 10-K, and any risk factors or cautionary statements included in any subsequent Quarterly Report on Form 10-Q or Current Report on Form 8-K, filed with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Among other things, for those statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the PSLRA. The Company does not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. The Company, its directors and executive officers, Peter W. Rodino, III and Robert Dickey, IV, are deemed to be “participants” (as defined in Section 14(a) of the Securities Exchange Act of 1934, as amended) in the solicitation of proxies from the Company’s stockholders in connection with the Annual Meeting. The Company filed its definitive proxy statement (the “Definitive Proxy Statement”) and a universal proxy card with the SEC on November 4, 2024 in connection with such solicitation of proxies from the Company’s stockholders. The Definitive Proxy Statement contains information regarding the identity of the participants, and their direct and indirect interests, by security holdings or otherwise, in the Company’s securities and can be found in the section titled “Principal Stockholders” of the Definitive Proxy Statement and available . Information regarding subsequent changes to their holdings of the Company’s securities can be found in the SEC filings on Forms 3, 4, and 5, which are available on the Company’s website available or through the SEC’s website at . Stockholders will be able to obtain the Definitive Proxy Statement, any amendments or supplements thereto and other documents filed by the Company with the SEC at no charge at the SEC’s website at . Copies will also be available at no charge at the Company’s website at . ______________________________ 1 The Activist Group’s . 2 the March 2016 , filed with the SEC on March 16, 2016 (emphasis added). 3 ; the . 4 (emphasis added). 5 December 28, 2023, Opinion of the Delaware Court of Chancery: (emphasis added). 6 (emphasis added). 7 (emphasis added). 8 (emphasis added). 9 , 2022 WL 16543834, at *32 (Del. Ch. Oct. 28, 2022). (emphasis added). 10 December 28, 2023, Opinion of the Delaware Court of Chancery: (emphasis added). 11 July 29, 2024, Order on Motion for Reargument of the Delaware Supreme Court. View source version on : CONTACT: Investor Contact: JTC Team, LLC Jenene Thomas 908-824-0775 Media Contact: Longacre Square Partners Joe Germani / Miller Winston KEYWORD: FLORIDA DELAWARE UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY INFECTIOUS DISEASES HEALTH PHARMACEUTICAL ONCOLOGY SOURCE: AIM ImmunoTech Inc. Copyright Business Wire 2024. PUB: 11/27/2024 03:30 PM/DISC: 11/27/2024 03:29 PMNone
Herbert looks to maintain interception-free streak when Chargers host BuccaneersHouston Texans wide receiver Nico Collins scored a touchdown against the Tennessee Titans in his most recent home game and tossed the ball to a child in the stands pleading for it. On Thursday, Collins told reporters the NFL did not approve and assessed him a fine of about $5,000. "It's for the kids," Collins said. "I seen he was screaming and was thinking, ‘Here you go, big dog. Here's the ball.'" Collins said he was not penalized last season on the handful of occasions he threw a ball into the stands, so he wasn't expecting a fine. But making a child's day was "definitely worth it." The 25-year-old said he plans to appeal the fine, but if it isn't overturned, he'll pay up. "The only thing that matters was making that kid happy," he said. "He ain't never going to forget that moment. So that's all that matters to me." Collins followed up a 92-yard, one-touchdown performance that day against Tennessee with eight receptions for 119 yards last week at Jacksonville. The fourth-year wideout is Houston's leading receiver despite missing five games due to a hamstring injury. He has caught 49 passes for 832 yards and four touchdowns in just eight appearances. --Field Level Media
Chiefs' Isiah Pacheco and Charles Omenihu Remain Limited, Week 12 in QuestionWhen I learned about Normatec boots, my recovery life changed forever. Courtesy Normatec At GOLF.com, we stumble across all sorts of goodies. Here, we unveil some of our favorites from the past year. Why LeBron’s Hyperice Normatec boots were the best thing I tried in 2024 LeBron James is said to spend upwards of $1.5 million per year on health and nutrition. It’s an investment, he says, in himself, his career, and his legacy. And a stunning one when you do the math, ringing in at a little more than $4,000 a day . How, exactly, does a person spend $4,000 daily on his health and wellness? About five years ago, I thought I’d found the answer. It was the heart of the NBA season and LeBron was in the midst of (another) statistical tear when I opened Instagram and spotted a photo. James was wearing what appeared to be the legs to an astronaut suit , fully inflated and extended out over a long table. Outside of images from NASA, I’d never seen a product like it before. I didn’t know where it was from. I didn’t even know how to Google it. But I was fascinated. A few years later, my girlfriend Jamie decided to run the Chicago marathon. When it came time to book accommodations for race weekend, we decided on the Westin River North because we’d heard about a “ runner’s club ” program operated by the hotel chain at each of the six “major” marathons. Westin, we were told, invested thousands in the latest-and-greatest tech for runners, which “runner’s club” guests at the hotel were free to use at their leisure throughout race weekend. On our first day there, I walked down to the lobby and saw it. The space pants — Lebron’s space pants — sat empty next to a strange-looking lawn chair. With no competitive plans for the weekend other than deep dish and light beer, I turned to Jamie. “Do you mind if I try?’ Five minutes later, I was strapped in. And as the pants inflated and my chair tilted back, I learned for the first time about the product that had fascinated me years earlier. Not space pants but Normatec Compression Boots — a still-new piece of recovery technology revolutionizing the way athletes managed their health. The pants were essentially big balloons, an on-site PT told me, trained to inflate and deflate in highly specific ways to promote blood flow and speed up recovery. The secret sauce was something called dynamic compression technology , which encouraged circulation of the legs, flushed lactic acid and metabolic waste, and mimicked a natural muscle “pump.” As my “cycle” continued, rhythmically squeezing my feet, calves, knees and thighs, I looked around the lobby. Twenty other pairs of NormaTec Boots lined the area, each with its own zero-gravity chair. I turned back to the PT. “They must have spent a fortune on this,” I said, remembering LeBron’s $1.5 million bill. “Actually, they probably spent less than you think,” she said. As it turned out, she was right. True to my memory, Normatec’s technology had sparked a revolution in high-level professional sports, particularly in the NBA, about five years earlier. At the time, the boots cost a fortune, and the technology they promised was still very much space-age, but stars like LeBron were early adopters. Soon, the rest of the league took notice, with players eager to lessen the stress of an 82-game season of sprinting and jumping on their joints. The popularity helped plans materialize to turn the boots into a full-fledged consumer product, which was how Westin had eventually gotten into the game. “Lots of people actually just ... own these ,” the PT said. I laughed then. But I wasn’t laughing 15 minutes later, when my 30-minute “cycle” ended. I’d gotten off a transcontinental flight from the Ryder Cup two days earlier, then hopped on another flight to Chicago that morning. And yet, as I took in the lobby flexing my legs, I felt positively springy. The feeling lingered for the rest of the day. After a pre-marathon jog the next morning, I stumbled through the lobby to see lines of runners forming in front of the boots. I didn’t have to imagine their relief, I saw it on Jamie’s face. “That rocks ,” she said. The months that followed that first experience flew by, but my memory of the boots did not. Evidently, the same could be said for Jamie, who was still running and suddenly sharing LeBron’s eagerness to remove some stress from her legs. As the spring arrived, I went on a golf trip, playing 36 holes per day with some of my coworkers. I went to bed each night with my knees aching, silently dreaming I could get an afternoon “cycle” with the boots on. Thankfully, with another marathon (and golf trip) looming, I don’t have to wait too much longer. Normatec is dropping the price of their boots for Black Friday by $100, and while the cost is still very much nosebleed , it’s not quite a $1.5 million nosebleed. As far as I’m concerned, that’s well worth the benefit for a pair of highly active walkers (golf) and runners (marathons). Now if you don’t mind, I have a Turkey Trot to recover from. Latest In Gear Golf.com Editor James Colgan is a news and features editor at GOLF, writing stories for the website and magazine. He manages the Hot Mic, GOLF’s media vertical, and utilizes his on-camera experience across the brand’s platforms. Prior to joining GOLF, James graduated from Syracuse University, during which time he was a caddie scholarship recipient (and astute looper) on Long Island, where he is from. He can be reached at james.colgan@golf.com.Vancouver Island First Nation whose ancestors met explorer Capt. Cook sue province
Pacheco's 18 lead Mount St. Mary's past Howard 79-75TCU leading scorer Frankie Collins will miss rest of season after breaking left foot
Trump selects Jared Kushner’s father, Charles Kushner, for ambassador to FranceValve has officially kicked off the annual Steam Autumn Sale for 2024, with thousands of games heavily discounted. Whether you’re stocking up for the holiday period, or you’re a fellow Aussie who’s recently got hands on the , there’s plenty of fantastic games now going cheap – including new releases, underrated hits, and the best AAAs and indies of the past. At a glance, the spotlight deals are pretty good. is going for AUD $61.53. is AUD $86.21. The early access version of is also on sale, for AUD $39.55. There’s also discounts on , the entire franchise, and more. The best deals beyond these are much harder to spot – they require diving deep into the bowels of Steam, checking out your wishlists, and ruminating on the best releases you might’ve missed this year. To that end, read on. The best deals we’ve spotted in the Steam Autumn Sale 2024 (so far) . You can browse the best deals of the Steam Autumn Sale 2024 for yourself .OpenAI's legal battle with Elon Musk reveals internal turmoil over avoiding AI 'dictatorship'By Arathy Somasekhar (Reuters) -Oil prices were little changed on Wednesday, pressured by a large surprise build in U.S. gasoline stocks and worries about U.S. interest rate cuts next year, but prices drew support from concerns about supply eased after a ceasefire deal between Israel and Hezbollah. Brent crude futures settled 2 cents higher at $72.83 a barrel. U.S. West Texas Intermediate crude slipped 5 cents to $68.72. U.S. gasoline stocks rose by 3.3 million barrels in the week to 212.2 million barrels, the Energy Information Administration said, counter to analysts’ expectations in a Reuters poll for a draw of 46,000 barrels. Crude stocks fell by 1.8 million barrels in the week ended Nov. 22, the EIA added, far exceeding analysts’ expectations in a Reuters poll for a draw of 605,000 barrels. Market sources, citing the American Petroleum Institute, had said on Tuesday that oil inventories fell by 5.94 million barrels and fuel inventories rose last week. “It is surprising to see gasoline inventories building so much and implied demand not really budging week-on-week, given expected record travel this Thanksgiving,” said Matt Smith, an analyst at Kpler. Oil prices also were dented by U.S. data showing progress on lowering inflation appears to have stalled in recent months, which could narrow the scope for the Federal Reserve to cut interest rates in 2025. Traders added to bets the U.S. central bank will lower borrowing costs by 25 basis points at its Dec. 17-18 meeting, according to CME Group’s FedWatch tool. However, they anticipate the Fed will leave rates unchanged at its meetings in January and March. Slower-than-expected rate cuts would keep the cost of borrowing elevated, which could slow economic activity and dampen demand for oil. Both oil benchmarks settled lower on Tuesday after Israel agreed to a ceasefire deal with Lebanon’s Hezbollah group, effective Wednesday after both sides accepted the agreement brokered by the U.S. and France. The ceasefire started on Wednesday. “The real question will be for how long it (the ceasefire) will truly be honoured,” said Dennis Kissler, senior vice president of trading at BOK Financial. Oil gained support after sources from the OPEC+ group, which includes the Organization of the Petroleum Exporting Countries and allies led by Russia, said it is discussing a further delay to the oil output increase set for January. The group, which produces about half of the world’s oil, had aimed to gradually ease production cuts through 2024 and 2025, but weaker global demand and rising output outside OPEC+ have cast doubt on that plan. The decision will be made at a Dec. 1 meeting. The heads of commodities research at Goldman Sachs and Morgan Stanley said oil prices are undervalued, citing a market deficit and risk to Iranian supply from possible sanctions when U.S. President-elect Donald Trump takes office. Sources also told Reuters on Tuesday that crude oil would not be exempt from the 25% tariffs that Trump has threatened to impose on all products coming into the U.S. from Mexico and Canada. Oil industry analysts and traders warned the move would likely raise oil prices for U.S. refiners, squeezing margins and driving up the cost of fuel. (Reporting by Arunima Kumar in Bengaluru, Yuka Obayashi in Tokyo and Emily Chow in Singapore; editing by David Goodman, Jason Neely, Jonathan Oatis, David Gregorio and Paul Simao) Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibilty for its content. var ytflag = 0;var myListener = function() {document.removeEventListener('mousemove', myListener, false);lazyloadmyframes();};document.addEventListener('mousemove', myListener, false);window.addEventListener('scroll', function() {if (ytflag == 0) {lazyloadmyframes();ytflag = 1;}});function lazyloadmyframes() {var ytv = document.getElementsByClassName("klazyiframe");for (var i = 0; i < ytv.length; i++) {ytv[i].src = ytv[i].getAttribute('data-src');}} Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );
Comedian Eddie Griffin Mocks Jaguar Ad Featuring Crossdressers but No Car: ‘All You Them/Theys, Y’all Lost’Police deny sitting on evidence as Netflix doc brings renewed attention to JonBenet Ramsey’s killingCity of Edmonton planning to sell 2 downtown office buildings, relocate hundreds of staff
None
Editorial cartoon: Bob Englehart on political silosOlive Garden responds after diner claims to find 'letters' on breadstick: 'We are concerned to see this'
Martin St. Louis Torches the Officials Repeats Same Fiery Answer to Five Questions in One-Minute PresserThe Ducks will ring in December by hosting the Ottawa Senators on Sunday in a matchup of teams that are an eyelash under .500 with designs on gaining some upward momentum. They’ll enter the clash with identical .477 points percentages that situate them near the bottom of their respective divisions but not far behind a crowded pack of middling clubs. The Ducks have had more of a defensive inclination while the Senators have shown more scoring pop to date. Ducks coach Greg Cronin said his team hadn’t “had too many stinkers” of late, and that’s been reflected by their 5-3-1 record across their past nine games, with four of their five-plus-goal games this season arriving in that span. “Since we got back from that New York trip, I think we’ve been on a pretty good path in terms of playing with an identity and competing,” Cronin said. They had to grind hard on Black Friday, when they played what Cronin described as something of a postseason-style game against the Kings at Honda Center. Though they fell 2-1 to what veteran forward Ryan Strome described as a “mature, veteran team” that they couldn’t quite edge past despite playing a “disciplined, structured and north-south” game, the Ducks still felt they carried forward some positive indicators from their recent play. “It was a good hockey game. We competed hard. I thought we dictated a lot of the game. We played similar to the way we’ve been playing,” Strome said. Kings coach Jim Hiller concurred. With teams frequently playing the Southern California franchises back to back, he and Cronin get constant looks at one another’s teams during pre-scouts, and Hiller assessed the Ducks’ performance quite favorably. “I thought – we’ve played them this year, I’ve scouted them this year – I thought that’s the best game they’ve played this year. I thought they played very well,” Hiller said. Time will tell if Sunday’s match elicits similar plaudits from Ottawa coach Travis Green, who spent parts of two seasons with the Ducks as a player and is in his first year as the Sens’ head coach after previously guiding the Vancouver Canucks and New Jersey Devils briefly. Though Brock McGinn has made some progress in his return, he and Robby Fabbri remained unavailable. So, too, did Leo Carlsson, whose upper-body injury has kept him out of the Ducks’ past two matches. Cam Fowler will be a game-time decision. Troy Terry has four points across his three-game scoring streak, while Trevor Zegras just snapped a four-gamer that saw him compile six points. For Ottawa, forwards Tim Stützle and Drake Batherson each have seven points in the Sens’ past five outings. Captain Brady Tkachuk, whom Cronin suggested could be a model for his own power forward Mason McTavish, has racked up five points during a three-game surge. Those are the three Senators scoring above a point per game this season, with Stützle’s 28 points in 22 games leading the way. When: 5 p.m. Sunday Where: Honda Center How to watch: Victory+
NoneMary Fowler's has been overshadowed by a serious injury to captain Alex Greenwood, with fans left devastated for the English star. Fowler and helped City defeat St Polten in the women's Champions League on Thursday night to maintain top spot in Group D. It was Fowler's second win in two games since returning to action following her decision to against Brazil and Chinese Taipei to prioritise her physical and mental health. The break appears to have done the trick, with Fowler scoring a cracking goal earlier this week in the Super League and following it up with another solid performance on Wednesday night. But her successful return was overshadowed when Greenwood went down with a horrible-looking injury against St Polten. The England defender went down in obvious pain during the first half and was clutching her left knee. She covered her face with her shirt as she was carried off the field on a stretcher. City will be hoping the injury isn't as bad as it looked, but there are fears she might have done her ACL. There was been a plague of ACL injuries to hit the women's game in recent years, with Matildas captain with one. Greenwood's injury also marred a night which saw a debut to remember for 18-year-old Lily Murphy, who only signed her first professional contract last week. The teenager was lively throughout the game and held her arms aloft in delight when she tapped in the opening goal in the 55th minute, with Kerstin Casparij also scoring her first goal for the club. The victory maintained City's perfect record in the Champions League. However Barcelona's 3-0 victory over Hammarby means Fowler's team are not yet assured of top spot in the group ahead of a trip to Catalonia next week. Hope she's back on the pitch soon 🙏 — Aabid (@theabuabid) Was absolutely heartbreaking to see her so distressed, wish the cameras would have for respect for the players and not show them in those situations. — Toni Hazell (@tonihazell) I’m praying it’s not as bad as it looked. 🤞🏻🤞🏻 — Nicole (@nrstanley01) If Alex Greenwood has torn her ACL cancel the whole of next years euros I’m so serious — Eden Morgan (@EdenVMorgan) genuinely praying that alex greenwood is okay and makes a safe and speedy recovery. such an important player for both club and country right now in such consistent form, an absolutely heartbreaking thing to see☹️ — emily (@emilykatrinah_) Wishing a super speedy recovery. Such a warrior of a player, she doesn’t go off the pitch without a real reason. That looked serious. — Jenni 🏳️🌈❤️🔥🏳️⚧️ (@Jenwah) Meanwhile, fellow Matildas players Caitlin Foord and Kyra Cooney-Cross started in Arsenal's 3-1 win at Valerenga, while Steph Catley wasn't required. Alessio Russo scored a double as the Gunners took a big step towards securing top spot in Group C. Arsenal were already guaranteed a quarter-final berth after a narrow victory at home to Juventus last month, but the three points in Norway keep alive the prospect of beating current leaders Bayern Munich to first position in the group. First-half goals by Russo and Frida Maanum put Renee Slegers' side in control before England forward Russo grabbed a second after the break. Foord was brilliant on the wing and set up a number of attacking raids, including one that resulted in Maanum's goal. Arsenal earned an eighth win in nine under interim coach Slegers ahead of Wednesday's visit of Bayern, who are one point ahead of the English club following a 4-0 triumph over Juventus.
If You’ll Be Bed And Couch Rotting For The Holidays (Lucky You), These 34 Things WIll Make It Even BetterUoH Professor Highlights Advantages of Digital Payments
Vancouver Island First Nation whose ancestors met explorer Capt. Cook sue provinceDEAR ABBY: Six years ago, my family lost my mother, who was the rock of our family. Two weeks after that, my family started falling apart. My older brother, younger sister and I no longer speak. My brother and I got in a physical confrontation and haven’t spoken since. A year later, I suffered a massive heart attack. I was at death’s door. My doctors said it was a miracle I survived. I’m blessed to be here, but since then, not one family member has reached out. The story of my survival was all over social media and even on a few TV newscasts. My heart function is low, and I had a defibrillator implanted. I have been missing my family more and more, but I’m also afraid my heart will get broken. We have made mistakes, and I know I’m also at fault. I feel awful about what happened, but I’m hurt that no one reached out to my wife or daughter asking if I was OK or if they needed anything. I recently had some contact with my brother’s son, and we have been texting, but I have yet to hear from my brother. My family is growing with grandkids, and I would love to reconnect our families before it’s too late. Is it too late? – Estranged in Pennsylvania DEAR ESTRANGED: Maybe, maybe not. If you haven’t already, write or call your brother and make a formal apology for what happened between you. While you are at it, do the same with the rest of your family members. Tell them you are sorry, that none of you is getting any younger and you would like to be part of the family again. I can’t predict the outcome, but this would be a good start. I wish you luck. With the passage of time, people sometimes gain a better perspective. DEAR ABBY: My sister “Mary Ann” is a hoarder. She refuses all offers of assistance (physically and emotionally) to clear her home of the overwhelming amount of stuff that negatively impacts her life. Our extended family is thrilled that she has finally started to make an effort to sort through some of her “treasures.” Unfortunately, we have now become recipients of birthday and Christmas gifts, some of which are opened, used, dusty and have animal fur on them. We do not want or need these “gifts.” I sense that unloading these items on us gives Mary Ann a feeling of comfort and keeps her from making difficult decisions that will lead to truly changing her thinking related to letting go of her junk. How do we politely (and firmly) express to Mary Ann that we have no desire to receive her hoard, bit by bit, without reversing the progress she has made in attempting to address her disorder? – Unhappy Recipient in Missouri DEAR RECIPIENT: You are not going to “fix” Mary Ann. Be glad she is taking baby steps to help herself. I do not think it would be helpful to “politely express” that you have no desire to receive her hoard, bit by bit. Instead, accept the items and then quietly donate them or give them to someone who might use them. Dear Abby is written by Abigail Van Buren, also known as Jeanne Phillips, and was founded by her mother, Pauline Phillips. Contact Dear Abby at www.DearAbby.com or P.O. Box 69440, Los Angeles, CA 90069.
Women more likely to need walking aids but less likely to use them – studyDemocrat Bob Casey concedes to Republican David McCormick in Pennsylvania Senate contestThe Ducks will ring in December by hosting the Ottawa Senators on Sunday in a matchup of teams that are an eyelash under .500 with designs on gaining some upward momentum. They’ll enter the clash with identical .477 points percentages that situate them near the bottom of their respective divisions but not far behind a crowded pack of middling clubs. The Ducks have had more of a defensive inclination while the Senators have shown more scoring pop to date. Ducks coach Greg Cronin said his team hadn’t “had too many stinkers” of late, and that’s been reflected by their 5-3-1 record across their past nine games, with four of their five-plus-goal games this season arriving in that span. “Since we got back from that New York trip, I think we’ve been on a pretty good path in terms of playing with an identity and competing,” Cronin said. They had to grind hard on Black Friday, when they played what Cronin described as something of a postseason-style game against the Kings at Honda Center. Though they fell 2-1 to what veteran forward Ryan Strome described as a “mature, veteran team” that they couldn’t quite edge past despite playing a “disciplined, structured and north-south” game, the Ducks still felt they carried forward some positive indicators from their recent play. “It was a good hockey game. We competed hard. I thought we dictated a lot of the game. We played similar to the way we’ve been playing,” Strome said. Kings coach Jim Hiller concurred. With teams frequently playing the Southern California franchises back to back, he and Cronin get constant looks at one another’s teams during pre-scouts, and Hiller assessed the Ducks’ performance quite favorably. “I thought – we’ve played them this year, I’ve scouted them this year – I thought that’s the best game they’ve played this year. I thought they played very well,” Hiller said. Time will tell if Sunday’s match elicits similar plaudits from Ottawa coach Travis Green, who spent parts of two seasons with the Ducks as a player and is in his first year as the Sens’ head coach after previously guiding the Vancouver Canucks and New Jersey Devils briefly. Though Brock McGinn has made some progress in his return, he and Robby Fabbri remained unavailable. So, too, did Leo Carlsson, whose upper-body injury has kept him out of the Ducks’ past two matches. Cam Fowler will be a game-time decision. Related Articles Troy Terry has four points across his three-game scoring streak, while Trevor Zegras just snapped a four-gamer that saw him compile six points. For Ottawa, forwards Tim Stützle and Drake Batherson each have seven points in the Sens’ past five outings. Captain Brady Tkachuk, whom Cronin suggested could be a model for his own power forward Mason McTavish, has racked up five points during a three-game surge. Those are the three Senators scoring above a point per game this season, with Stützle’s 28 points in 22 games leading the way. When: 5 p.m. Sunday Where: Honda Center How to watch: Victory+
Man who set off makeshift bomb outside Alabama attorney general's office sentenced to nine years
- Previous:
- Next: 188 jili tv
